跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-DULOXETINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AURO-DULOXETINE
Authorized
STANDARD
AURO-DULOXETINE
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c4196b65569905e6
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
c4196b65569905e6
Drug Approval Canada Name
AURO-DULOXETINE
Product Name
AURO-DULOXETINE
Status
Marketed
Status Date
2016-05-02
Original Market Date
2016-05-02
Din
02436655
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX21 DULOXETINE
Atc Name
n 06 ax 21
Aig Number
0152350002
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
DULOXETINE (DULOXETINE HYDROCHLORIDE)
60 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c4196b65569905e6
Type
Standard
Back to Health Canada Approvals